Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

YH Chung, H Cai, NF Steinmetz - Advanced Drug Delivery Reviews, 2020 - Elsevier
Viral nanoparticles (VNPs) encompass a diverse array of naturally occurring nanomaterials
derived from plant viruses, bacteriophages, and mammalian viruses. The application and …

[HTML][HTML] The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease

M Colom-Cadena, T Spires-Jones, H Zetterberg… - Alzheimer's research & …, 2020 - Springer
Background Synapse damage and loss are fundamental to the pathophysiology of
Alzheimer's disease (AD) and lead to reduced cognitive function. The goal of this review is to …

Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons

S Moonen, MJ Koper, E Van Schoor… - Acta …, 2023 - Springer
The major neuropathological hallmarks of Alzheimer's disease (AD) are amyloid β (Aβ)
plaques and neurofibrillary tangles (NFT), accompanied by neuroinflammation and neuronal …

[HTML][HTML] Retinal pathological features and proteome signatures of Alzheimer's disease

Y Koronyo, A Rentsendorj, N Mirzaei, GC Regis… - Acta …, 2023 - Springer
Alzheimer's disease (AD) pathologies were discovered in the accessible neurosensory
retina. However, their exact nature and topographical distribution, particularly in the early …

Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies

HA Elfawy, B Das - Life sciences, 2019 - Elsevier
Mitochondrial function is vital for normal cellular processes. Mitochondrial damage and
oxidative stress have been greatly implicated in the progression of aging, along with the …

[HTML][HTML] Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia

D Sepulveda-Falla, JS Sanchez, MC Almeida… - Acta …, 2022 - Springer
We describe in vivo follow-up PET imaging and postmortem findings from an autosomal
dominant Alzheimer's disease (ADAD) PSEN1 E280A carrier who was also homozygous for …

[HTML][HTML] Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy

SF Roemer, LT Grinberg, JF Crary, WW Seeley… - Acta …, 2022 - Springer
Neuropathologic criteria for progressive supranuclear palsy (PSP) proposed by a National
Institute of Neurological Disorders and Stroke (NINDS) working group were published in …

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

S Villeneuve, GD Rabinovici, BI Cohn-Sheehy… - Brain, 2015 - academic.oup.com
Amyloid-β, a hallmark of Alzheimer's disease, begins accumulating up to two decades
before the onset of dementia, and can be detected in vivo applying amyloid-β positron …

[HTML][HTML] Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART

SK Kaufman, K Del Tredici, TL Thomas, H Braak… - Acta …, 2018 - Springer
Alzheimer's disease (AD) is characterized by accumulation of tau neurofibrillary tangles
(NFTs) and, according to the prion model, transcellular propagation of pathological “seeds” …

[HTML][HTML] Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina

H Shi, Y Koronyo, A Rentsendorj, GC Regis… - Acta …, 2020 - Springer
Pericyte loss and deficient vascular platelet-derived growth factor receptor-β (PDGFRβ)
signaling are prominent features of the blood–brain barrier breakdown described in …